Recombinant RABV G (Zamerovimab Biosimilar) antibody

Catalog No. ABIN7598110

The Humanized Chimeric anti-RABV G (Zamerovimab Biosimilar) antibody has been validated for . It is suitable to detect RABV G (Zamerovimab Biosimilar) in samples from Lyssavirus rabies (RABV).

Quick Overview for Recombinant RABV G (Zamerovimab Biosimilar) antibody (ABIN7598110)

Target: RABV G (Zamerovimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Lyssavirus rabies (RABV)

Host: Humanized

Clonality: Chimeric

Conjugate: This RABV G (Zamerovimab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-RABV G (Zamerovimab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Zamerovimab Biosimilar Antibody

Specificity: G/Glycoprotein

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1, kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for RABV G (Zamerovimab Biosimilar)

Target: RABV G (Zamerovimab Biosimilar)

Alternative Name: Zamerovimab Biosimilar

Target Type: Biosimilar

Background: G/Glycoprotein

UniProt: O92284, P08667

CAS-No: 2419087-87-7